Cr(VI) salts are well known to be carcinogen, and are reduced by various cellular components to form cross-linked Cr(III) products. Organic compounds, such as gallic acid (GA) and ethyl gallate (EGA), reduce Cr(VI) to Cr(III) to form Cr(III)-gallate [Cr(III)-GA] and Cr(III)-ethyl gallate [Cr(III)-EGA] as final products. These Cr(III)-tannin complexes are DNA binders. The interaction of calf-thymus DNA with Cr(III)-GA and Cr(III)-EGA in aqueous solutions at physiological pH were studied at Cr(III)/DNA (phosphate) molar ratios (r) of 1 : 160, 1 : 80, 1 : 40, 1 : 20, 1 : 10, 1 : 4, and 1 : 2 using FTIR spectroscopy and capillary electrophoresis. An analysis by FTIR showed that at low concentrations (r = 1/80 and 1/40), Cr(III)-GA and Cr(III)–EGA mainly bind to the guanine N-7 atom of the G–C base pairs with minor perturbations of the A–T base pairs. At r > 1/20, a partial helix opening occurred with major perturbations of the G–C and A–T base pairs. At r > 1/10, aggregation of the Cr(III)-tannin–DNA complexes occurred. However, no DNA conformational changes were observed, and the DNA maintained the B-family structure. The binding constants of the Cr(III)-GA–DNA and Cr(III)-EGA–DNA were estimated to be 3.8 × 104 M−1 and 6.2 × 104 M−1, respectively, by Scatchard plots following capillary electrophoresis. These results suggest that the Cr(III)-tannin complexes are external DNA binders, and do not form a chelate with the DNA.
No takes yet. Share an insight, caveat, or question.
Arakawa et al. (2001) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: